Trial intelligence / Profile preview

Olmesartan and Adipose Tissue Inflammation in Obesity

NCT01684748Phase 4Completed

Sponsor
Virginia Tech
Start
Feb 2009
Primary completion
Aug 2011
Modality
Small Molecules
01

Overview

A Phase 4 trial of olmesartan in hypertension (HTN), sponsored by Virginia Tech. Started Feb 2009; status: completed.

02

Drugs

olmesartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01684748.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01684748.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call